Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07367100Not ApplicableRecruiting

A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic Stroke

Role: lead

NCT03601702Recruiting

EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke

Role: collaborator

NCT03898960Completed

Post Marketing Study to Evaluate the NIMBUS Device

Role: lead

NCT02190552Terminated

Analysis of Revascularisation in Ischemic Stroke With EmboTrap

Role: lead

All 4 trials loaded